Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 20.295.8813.6121.245.09

What is the latest Core EBITDA Growth ratio of LINCOLN PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of LINCOLN PHARMACEUTICALS is 20.29 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202420.29
Mar20235.88
Mar202213.61
Mar202121.24
Mar20205.09

How is Core EBITDA Growth of LINCOLN PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 20.29
245.07
Mar2023 5.88
-56.80
Mar2022 13.61
-35.92
Mar2021 21.24
317.29
Mar2020 5.09 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,093.4 Cr -0.2% -4.5% -6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,865.0 Cr -0.5% -8.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹173,574.0 Cr -2.4% 7.2% 50.6% Stock Analytics
CIPLA ₹118,710.0 Cr -0.7% -3.7% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,964.0 Cr -1.4% -3.9% 19% Stock Analytics
DR REDDYS LABORATORIES ₹104,232.0 Cr 0.5% 5.6% 5.1% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-0.2%

-4.5%

-6.6%

SENSEX

-1%

1.4%

7.9%


You may also like the below Video Courses